Mineralys Therapeutics, Inc. (MLYS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$26
Day's range
$27.47

Mineralys Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CATALYS PACIFIC, LLC 05/14/2026 7.90 M $214.11 M   0.00% 9.54%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 7.69 M $208.40 M   5.04% 9.29%
SAMSARA BIOCAPITAL, LLC 05/15/2026 5.87 M $159.05 M   0.00% 7.09%
FMR LLC 05/15/2026 4.86 M $131.69 M   -3.88% 5.87%
BLACKROCK, INC. 05/13/2026 4.48 M $121.41 M   3.56% 5.41%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 3.36 M $91.00 M   328.31% 4.06%
STATE STREET CORP 05/15/2026 2.94 M $79.53 M   -7.82% 3.54%
CALIGAN PARTNERS LP 05/15/2026 2.77 M $75.11 M   0.00% 3.35%
05/15/2026 2.45 M $66.49 M   100.00% 2.96%
LAURION CAPITAL MANAGEMENT LP 05/14/2026 2.23 M $60.47 M   30.26% 2.69%
ORBIMED ADVISORS LLC 05/15/2026 2.05 M $55.61 M   109.39% 2.48%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 1.91 M $51.78 M   58.33% 2.31%
FRANKLIN RESOURCES INC 05/13/2026 1.78 M $48.35 M   -0.23% 2.15%
CAPTION MANAGEMENT, LLC 05/15/2026 1.75 M $47.44 M   43.33% 2.11%
ANDERA PARTNERS 05/11/2026 1.59 M $43.13 M   0.00% 1.92%
SR ONE CAPITAL MANAGEMENT, LP 05/14/2026 1.56 M $42.37 M   0.00% 1.89%
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 1.54 M $41.68 M   0.00% 1.86%
CAPTION MANAGEMENT, LLC 05/15/2026 1.52 M $41.24 M   24.02% 1.84%
POLAR CAPITAL HOLDINGS PLC 05/15/2026 1.50 M $40.66 M   7.11% 1.81%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 1.34 M $36.39 M   1.37% 1.62%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 1.34 M $36.30 M   198.43% 1.62%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 1.30 M $35.25 M   3.46% 1.57%
JENNISON ASSOCIATES LLC 05/06/2026 1.27 M $34.30 M   0.60% 1.53%
ARMISTICE CAPITAL, LLC 05/15/2026 1.18 M $31.86 M   73.96% 1.42%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.10 M $29.81 M   11.45% 1.33%
PICTET ASSET MANAGEMENT HOLDING SA 04/22/2026 1.03 M $28.02 M   21.29% 1.25%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 1.00 M $27.14 M   0.97% 1.21%
ALLIANCEBERNSTEIN L.P. 05/15/2026 975.96 K $35.42 M   5.79% 1.18%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 914.73 K $24.78 M   84.22% 1.10%
NANTAHALA CAPITAL MANAGEMENT, LLC 05/15/2026 895.48 K $24.26 M   690.47% 1.08%
D. E. SHAW & CO., INC. 05/15/2026 887.19 K $24.03 M   -22.90% 1.07%
AMERICAN CENTURY COMPANIES INC 05/15/2026 884.11 K $23.95 M   -2.64% 1.07%
MORGAN STANLEY 05/15/2026 849.18 K $23.00 M   32.79% 1.03%
CANDRIAM S.C.A. 04/30/2026 801.90 K $21.72 M   18.21% 0.97%
GOLDMAN SACHS GROUP INC 05/15/2026 785.04 K $21.27 M   -45.89% 0.95%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 750.00 K $20.32 M   2.74% 0.91%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 750.00 K $20.32 M   0.00% 0.91%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 725.90 K $19.66 M   27.17% 0.88%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 719.90 K $19.50 M   0.00% 0.87%
05/08/2026 706.66 K $19.14 M   100.00% 0.85%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 692.60 K $18.76 M   43.19% 0.84%
TUDOR INVESTMENT CORP ET AL 05/15/2026 655.60 K $17.76 M   22.38% 0.79%
TROLUCE CAPITAL ADVISORS LLC 05/15/2026 655.00 K $17.74 M   100.00% 0.79%
CITADEL ADVISORS LLC 05/15/2026 600.04 K $16.26 M   50.04% 0.72%
STEMPOINT CAPITAL LP 05/18/2026 533.38 K $14.45 M   83.89% 0.64%
MILLENNIUM MANAGEMENT LLC 05/15/2026 525.26 K $14.23 M   568.06% 0.63%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 05/15/2026 500.00 K $13.55 M   100.00% 0.60%
DAVERN CAPITAL PARTNERS, LP 05/14/2026 447.15 K $12.11 M   112.28% 0.54%
22NW, LP 05/15/2026 444.33 K $12.04 M   24.00% 0.54%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 443.90 K $12.03 M   -3.77% 0.54%

Mineralys Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 254 institutional investors and hedge funds held shares of Mineralys Therapeutics Inc. The most heavily invested institutionals were:

Catalys Pacific, LLC: 7.9 M

Andera Partners: 1.59 M

Pictet Asset Management Holding SA: 1.43 M

abrdn plc: 689,235

JENNISON ASSOCIATES LLC: 382,747

Bank of New York Mellon Corp: 158,550

133.51% of Mineralys Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 93.69 M shares in the last 24 months. This purchase volume represents approximately $2.55 B in transactions.